Short Communication:Influence of Active Tuberculosis on Chemokine and Chemokine Receptor Expression in HIV-Infected Persons
- 1 December 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 21 (12) , 997-1002
- https://doi.org/10.1089/aid.2005.21.997
Abstract
Tuberculosis (TB) is the major opportunistic infection of HIV-1-infected patients in developing countries. Concurrent infection with TB results in immune cells having enhanced susceptibility to HIV-1 infection, which facilitates entry and replication of the virus. Cumulative data from earlier studies indicate that TB provides a milieu of continuous cellular activation and irregularities in cytokine and chemokine circuits that favor viral replication and disease progression. To better understand the interaction of the host with HIV-1 during active tuberculosis, we investigated in vivo expression of the HIV-1 coreceptors, CCR5 and CXCR4, and circulating levels of the inhibitory β-chemokines, macrophage inflammatory protein-1-α (MIP-1α), macrophage inflammatory protein-1-β (MIP-1β), and regulated upon activation T cell expressed and secreted (RANTES), in HIV-positive individuals with and without active pulmonary tuberculosis. We found a significant decrease from normal in the fraction of CD4+ T cells expressing CCR5 and CXCR4 in individuals infected with HIV. However, CCR5 and CXCR4 expression did not differ significantly between HIV patients with and without tuberculosis. Higher amounts of MIP-1α, MIP-1β, and RANTES were detected in plasma of HIV-1-positive individuals, particularly those with dual infection, although the increase was not found to be statistically significant.Keywords
This publication has 48 references indexed in Scilit:
- CCR5 Is the Major Coreceptor Used by HIV-1 Subtype C Isolates from Patients with Active TuberculosisAIDS Research and Human Retroviruses, 2001
- CCR5 and CXCR4 chemokine receptor expression and β-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapyClinical and Experimental Immunology, 1999
- Phenotypic Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Isolates of Ethiopian AIDS PatientsAIDS Research and Human Retroviruses, 1999
- CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1α and MIP-1βAIDS, 1997
- Role of β-Chemokines in Suppressing HIV ReplicationScience, 1996
- RANTES, MIP-1α and MIP-1β are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clonesAIDS, 1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease ProgressionThe Journal of Infectious Diseases, 1994
- Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1The Lancet, 1994
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991